Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference
Get Alerts MIRO Hot Sheet
Join SI Premium – FREE
EDEN PRAIRIE, Minn., May 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced its participation in the H.C. Wainwright Annual Global Investment Conference on May 24th, 2022.
Miromatrix Medical’s management is scheduled to present at the H.C. Wainwright Annual Global Investment Conference. Interested parties can access the webcast beginning Tuesday, May 24, 2022, at 7am ET, here.
About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.
Investor Contact
Greg Chodaczek
347-620-7010
[email protected]
Media Contact:
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Limited – Q1 2024 results presentation
- BHP and Carlton Trail College Building Mining Training Pathways in Saskatchewan
- Landmark Bancorp, Inc. Announces Conference Call to Discuss First Quarter 2024 Earnings
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!